Keep an eye on oversold shares of VXRT. The stock is gaining momentum after receiving US FDA approval to test its experimental oral COVID-19 vaccine.
“The IND clearance and the initiation of our Phase 1 clinical trial moves us a step closer to proving the superiority of our convenient oral COVID-19 solution in the clinic. We are thus excited to start enrollment for our Phase 1 this month,” says the company.
Let me show you my Step-by-Step BLUEPRINT that Returned 5,500% in the last 2 years!
Potentially Earn 6,438% More Per Year By Defying All Of The Regular, Ordinary, Common, Boundaries & Restrictions On Trading & Investing (Like Our Model Portfolio)...